193 related articles for article (PubMed ID: 9920461)
1. In vitro biotransformation of atrazine by rat liver microsomal cytochrome P450 enzymes.
Hanioka N; Jinno H; Kitazawa K; Tanaka-Kagawa T; Nishimura T; Ando M; Ogawa K
Chem Biol Interact; 1998 Nov; 116(3):181-98. PubMed ID: 9920461
[TBL] [Abstract][Full Text] [Related]
2. In vitro metabolism of chlorotriazines: characterization of simazine, atrazine, and propazine metabolism using liver microsomes from rats treated with various cytochrome P450 inducers.
Hanioka N; Jinno H; Tanaka-Kagawa T; Nishimura T; Ando M
Toxicol Appl Pharmacol; 1999 May; 156(3):195-205. PubMed ID: 10222312
[TBL] [Abstract][Full Text] [Related]
3. In vitro metabolism of simazine, atrazine and propazine by hepatic cytochrome P450 enzymes of rat, mouse and guinea pig, and oestrogenic activity of chlorotriazines and their main metabolites.
Hanioka N; Jinno H; Tanaka-Kagawa T; Nishimura T; Ando M
Xenobiotica; 1999 Dec; 29(12):1213-26. PubMed ID: 10647908
[TBL] [Abstract][Full Text] [Related]
4. Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation. Metabolic drug interactions.
Zhou XJ; Zhou-Pan XR; Gauthier T; Placidi M; Maurel P; Rahmani R
Biochem Pharmacol; 1993 Feb; 45(4):853-61. PubMed ID: 8452560
[TBL] [Abstract][Full Text] [Related]
5. Differential roles of cytochromes P450 2D1, 2C11, and 1A1/2 in the hydroxylation of bufuralol by rat liver microsomes.
Mimura M; Yamazaki H; Sugahara C; Hiroi T; Funae Y; Shimada T
Biochem Pharmacol; 1994 Jun; 47(11):1957-63. PubMed ID: 7912070
[TBL] [Abstract][Full Text] [Related]
6. The contribution of cytochrome P-450 isoenzymes to the metabolism of phenothiazine neuroleptics.
Daniel WA; Syrek M; Haduch A
Eur Neuropsychopharmacol; 2002 Oct; 12(5):371-7. PubMed ID: 12208554
[TBL] [Abstract][Full Text] [Related]
7. Comparative study on nobiletin metabolism with liver microsomes from rats, Guinea pigs and hamsters and rat cytochrome p450.
Koga N; Matsuo M; Ohta C; Haraguchi K; Matsuoka M; Kato Y; Ishii T; Yano M; Ohta H
Biol Pharm Bull; 2007 Dec; 30(12):2317-23. PubMed ID: 18057719
[TBL] [Abstract][Full Text] [Related]
8. Changes in rat liver cytochrome P450 enzymes by atrazine and simazine treatment.
Hanioka N; Jinno H; Tanaka-Kagawa T; Nishimura T; Ando M
Xenobiotica; 1998 Jul; 28(7):683-98. PubMed ID: 9711812
[TBL] [Abstract][Full Text] [Related]
9. The role of different cytochrome P450 isoforms in in vitro chloroform metabolism.
Testai E; De Curtis V; Gemma S; Fabrizi L; Gervasi P; Vittozzi L
J Biochem Toxicol; 1996; 11(6):305-12. PubMed ID: 9176742
[TBL] [Abstract][Full Text] [Related]
10. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
Kumagai Y; Lin LY; Hiratsuka A; Narimatsu S; Suzuki T; Yamada H; Oguri K; Yoshimura H; Cho AK
Mol Pharmacol; 1994 Feb; 45(2):359-65. PubMed ID: 7906857
[TBL] [Abstract][Full Text] [Related]
11. Dog liver microsomal P450 enzyme-mediated toluene biotransformation.
Hanioka H; Hamamura M; Kakino K; Ogata H; Jinno H; Takahashi A; Nishimura T; Ando M
Xenobiotica; 1995 Nov; 25(11):1207-17. PubMed ID: 8592870
[TBL] [Abstract][Full Text] [Related]
12. In vitro metabolism of tirilazad mesylate in male and female rats. Contribution of cytochrome P4502C11 and delta 4-5 alpha-reductase.
Wienkers LC; Steenwyk RC; Mizsak SA; Pearson PG
Drug Metab Dispos; 1995 Mar; 23(3):383-92. PubMed ID: 7628305
[TBL] [Abstract][Full Text] [Related]
13. Identification of metabolic pathways involved in the biotransformation of tolperisone by human microsomal enzymes.
Dalmadi B; Leibinger J; Szeberényi S; Borbás T; Farkas S; Szombathelyi Z; Tihanyi K
Drug Metab Dispos; 2003 May; 31(5):631-6. PubMed ID: 12695352
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
[TBL] [Abstract][Full Text] [Related]
15. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450-related differences between rats and mice in the metabolism of benzene, toluene and trichloroethylene in liver microsomes.
Nakajima T; Wang RS; Elovaara E; Park SS; Gelboin HV; Vainio H
Biochem Pharmacol; 1993 Mar; 45(5):1079-85. PubMed ID: 8461037
[TBL] [Abstract][Full Text] [Related]
17. Involvement of CYP2D1 in the metabolism of carteolol by male rat liver microsomes.
Umehara K; Kudo S; Odomi M
Xenobiotica; 1997 Nov; 27(11):1121-9. PubMed ID: 9413916
[TBL] [Abstract][Full Text] [Related]
18. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X
J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274
[TBL] [Abstract][Full Text] [Related]
19. CYP2C11 and CYP2B1 are major cytochrome P450 forms involved in styrene oxidation in liver and lung microsomes from untreated rats, respectively.
Nakajima T; Wang RS; Elovaara E; Gonzalez FJ; Gelboin HV; Vainio H; Aoyama T
Biochem Pharmacol; 1994 Aug; 48(4):637-42. PubMed ID: 8080435
[TBL] [Abstract][Full Text] [Related]
20. Characterization of six in vitro reactions mediated by human cytochrome P450: application to the testing of cytochrome P450-directed antibodies.
Schmider J; Greenblatt DJ; von Moltke LL; Harmatz JS; Duan SX; Karsov D; Shader RI
Pharmacology; 1996 Feb; 52(2):125-34. PubMed ID: 8851634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
